Table 2
Operative data

Variable	Total (n=49)	DD (n=28)	LD (n=21)	P-value
Duration of anesthesia (min)	625±113 (533–695)	592±104 (505–675)	670±113 (565–715)	0.015^A*
Duration of operation (min)	519±117 (435–588)	481±94 (409–550)	569±127 (463–620)	0.007^A*
Pre-anhepatic phase (min)	167±70 (115–195)	143±46 (110–164)	200±82 (153–205)	0.003^A*
Anhepatic phase (min)	86±40 (60–95)	79±24 (60–95)	96±53 (60–115)	0.139^A
Neohepatic phase (min)	269±49 (230–303)	266±50 (225–304)	274±48 (240–300)	0.560^A
Warm ischemic time (min)	44±17 (35–49)	42±15 (35–45)	47±18 (33 - 55)	0.389^A
Cold ischemic time (min)	280±159 (148–370)	372±140 (271–418)	156±80 (87–198)	0.000^A*
Estimated blood loss (mL)	6,615±4,860 (3,400–8,000)	8,229±5,270 (4,575–9,750)	4,463±3,268 (2,300–6,150)	0.006^A*
RBC transfusion (unit)	11.1±6.6 (6.0–13.0)	13.3±7.0 (9.3–15.0)	8.0±4.8 (4.5–11.0)	0.005^A*
FFP transfusion (unit)	14.7±7.3 (9.5–18.5)	17.3±6.3 (12.0–20.0)	11.3±7.2 (7.0–14.0)	0.003^A*
Platelet pheresis (unit)	0.5±0.6 (0.0–1.0)	0.6±0.7 (0.0–1.0)	0.24±0.44 (0.0–0.5)	0.020^A*
Postreperfusion syndrome	17 (34.7)	8 (16.3)	9 (18.4)	0.071^B

Values are presented as mean±standard deviation (interquartile range) or number (%).
DD, deceased donor; LD, living donor; RBC, red blood cell; FFP, fresh frozen plasma.
^AIndependent t-test was done.
^BChi-square test was done.
^*P<0.05 (LD vs. DD).